Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial


Phase 2 Results

Summary of Purpose

The purpose of this study is to compare the safety and efficacy of treating individuals with acute ischemic stroke with normobaric oxygen therapy (NBO, given within 9 hours of symptom onset), to standard medical treatment. Trial Stopped: Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded external medical monitor.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 October 2017.

1 Jan 2007 21 Dec 2006 1 Jun 2009 1 Jun 2009 1 Oct 2017 1 Jul 2010
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available